Editorial highlights applications of artificial intelligence in drug design, precision medicine, and biomarker discovery.
Artificial intelligence (AI) technologies have the potential to revolutionise traditional drug discovery and development. The applications of AI in four prominent areas of drug discovery-drug design, quantum computing, precision medicine and biomarker discovery-are all covered in this issue of Emerging Topics in Life Sciences and summarised in this editorial.
No takes yet. Share an insight, caveat, or question.
Dey et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: